Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 29, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	13,755	13,820	12,946	11,482	8,080	8,955
Market Cap Growth	-2.62%	6.75%	12.75%	42.11%	-9.78%	-9.54%
Enterprise Value	13,120	12,878	12,124	10,966	7,766	8,528
Last Close Price	137.96	136.50	131.76	119.44	85.17	95.85
PE Ratio	32.91	40.49	51.85	74.32	90.18	21.99
Forward PE	15.45	18.15	21.34	22.53	24.55	22.30
PS Ratio	5.11	5.87	6.86	7.71	7.13	8.56
PB Ratio	4.58	5.34	5.80	6.72	5.88	7.95
P/TBV Ratio	4.63	5.43	5.91	6.90	5.88	7.95
P/FCF Ratio	23.19	24.80	35.80	35.56	34.66	41.15
P/OCF Ratio	21.60	23.21	33.20	33.83	31.50	39.19
PEG Ratio	0.76	0.31	0.65	0.66	0.37	0.37
EV/Sales Ratio	4.89	5.47	6.43	7.37	6.85	8.15
EV/EBITDA Ratio	23.02	21.11	29.14	41.44	35.51	25.37
EV/EBIT Ratio	24.28	22.09	30.71	44.04	37.38	26.04
EV/FCF Ratio	22.12	23.11	33.53	33.96	33.32	39.19
Debt / Equity Ratio	0.16	0.19	0.19	0.15	0.32	0.37
Debt / EBITDA Ratio	0.76	0.76	0.99	0.94	1.88	1.19
Debt / FCF Ratio	0.81	0.89	1.19	0.81	1.89	1.90
Asset Turnover	0.69	0.68	0.67	0.67	0.60	0.69
Inventory Turnover	17.15	15.99	16.48	14.85	11.71	12.59
Quick Ratio	2.89	3.06	2.25	2.49	3.65	5.14
Current Ratio	3.38	3.40	2.45	2.70	3.96	5.45
Return on Equity (ROE)	14.96%	14.16%	12.68%	10.03%	7.17%	46.20%
Return on Assets (ROA)	8.66%	10.46%	8.78%	7.01%	6.82%	13.46%
Return on Invested Capital (ROIC)	16.07%	22.51%	22.75%	17.26%	19.95%	54.61%
Return on Capital Employed (ROCE)	14.90%	18.20%	15.20%	13.60%	11.40%	21.20%
Earnings Yield	3.11%	2.47%	1.93%	1.35%	1.11%	4.55%
FCF Yield	4.31%	4.03%	2.79%	2.81%	2.89%	2.43%
Buyback Yield / Dilution	1.30%	-2.67%	-2.12%	-1.02%	-0.10%	-2.19%

Updated Oct 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q